Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the ...
1hon MSN
Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage study
The study, which followed patients for over five years, found that those who received the regimen were nine times more ...
Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We conducted a ...
A previous trial involving patients with metastatic prostate cancer that was resistant to androgen pathway modulation (formerly referred to as castration-resistant) showed that adding talazoparib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results